Clinical trial
A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and…
NCT00302458 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00302458 |
|---|---|
| Title | A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults |
| Official title | A Double-blind, Randomized, Placebo-controlled, Crossover Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | OROS-Methylphenidate, Immediate Release Methylphenidate, Placebo |
| Enrollment | 44 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 14, 2006 |
| Last update posted | Feb 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: